CHINA—Kingworld Medicines Group Limited, a prominent player in healthcare distribution, has officially inaugurated its Kingworld Longde Life and Health Industrial Park in Shenzhen’s Bao’an Technology City, located in the Longgang District.
The park’s opening was celebrated with an investment promotion conference, an investor tour, and an official launch ceremony, marking a pivotal milestone in Kingworld’s three-decade journey in the healthcare industry.
This state-of-the-art facility is set to become a national pharmaceutical incubation and investment hub, contributing significantly to the Greater Bay Area’s development.
With the park’s opening, Kingworld partnered with Foci to unveil a new product, the “Foci Kingworld An Gong Niu Huang Wan,” further diversifying its healthcare portfolio.
The Longde Health Industrial Park aligns with China’s national health industry strategy and complements Shenzhen and Longgang District’s industrial development plans.
Strategically situated at the intersection of Shenzhen’s Eastern High-speed Rail New Town and International Low-Carbon City, the park spans 10,000 square meters with a total construction area of 57,000 square meters.
It boasts cutting-edge production facilities and essential infrastructure, including pharmaceutical waste and wastewater treatment systems, backup power supplies, and other advanced amenities to support the diverse needs of resident enterprises.
The industrial park is a strategic initiative under Kingworld’s Fifth Five-Year Plan, positioned as a platform for innovation and collaboration.
Leveraging Kingworld’s robust global pharmaceutical supply chain, extensive sales network, and marketing expertise, the park aims to support resident enterprises in expanding market access.
It offers tailored professional assistance in areas such as financing, policy guidance, and legal services to accelerate the development and growth of pharmaceutical projects.
Moreover, the park hosts several high-end research institutions, including the Hong Kong Medicine Landing Hub, the Shenzhen-Hong Kong Traditional Chinese Medicine Center, and a Pharmaceutical GSP Supply Chain Distribution Center.
These facilities promote collaboration between research experts, medical institutions, and distribution channels, driving innovation in the biomedical sector across the Greater Bay Area.
Mr. Zhao Li Sheng, Chairman of Kingworld Medicines, emphasized the park’s role as a green, intelligent hub for research, production, and logistics.
He hoped it would become a landmark in Longgang’s pharmaceutical industry, fostering technological innovation and contributing to the region’s healthcare advancements.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
